F. Li et al., REGIONAL QUANTITATIVE-ANALYSIS OF TAU-POSITIVE NEURONS IN PROGRESSIVESUPRANUCLEAR PALSY - COMPARISON WITH ALZHEIMERS-DISEASE, Journal of the neurological sciences, 159(1), 1998, pp. 73-81
In patients with progressive supranuclear palsy (PSP), various tau-pos
itive abnormal structures are found in the cerebral cortex as well as
in the subcortical nuclei. Similar tau-positive abnormalities are also
identified in cortico-basal degeneration (CBD). It is therefore quest
ionable as to whether PSP can be neuropathologically differentiated fr
om CBD. It also remains unclear whether neurofibrillary tangles (NFT)
in the cerebral cortex of PSP patients consist of PSP-NFT or concomita
nt Alzheimer's disease (AD)-NFT, although there have been some reports
suggesting that PSP- and AD-NFT are different with respect to distrib
ution pattern and biochemical character. In this study, a regional qua
ntitative analysis of the distribution and antigenicity of tau-positiv
e neurons (TPN) was performed in PSP cases and compared with that in A
D cases. TPN consisted of NFT with tangle-formation and pretangle neur
ons (PN) without tangle-formation. In addition, NFT were subdivided in
to mature and immature NFT according to the difference of staining pro
perties with anti-tau-related antibodies. The comparison of the TPN of
the PSP cases with those of the AD cases revealed that the degree of
tangle-formation in the TPN of AD was similar in all of the examined r
egions, while that in the TPN of PSP varied according to the region an
d case. Moreover, the NFT in the PSP and AD cases had different distri
butions according to the cortical layer and subnucleus, even in the co
mmon predilection sites of PSP and AD, suggesting that NFT in these re
gions of the PSP cases consist mainly of PSP-NFT. In addition, the PSP
cases could be divided into two groups according to the difference of
the tangle-formation of TPN; group I with typical PSP pathology and g
roup II with atypical PSP pathology similar to CBD. This suggests that
there is a continuity between PSP and CBD with respect to the distrib
ution and antigenicity of TPN. (C) 1998 Elsevier Science BN. All right
s reserved.